Date: May 24, 2021

Quarter: Monday Q3

Minutes Approved as Presented 

This is to approve minutes via general consent. "You have received the minutes. Are there any corrections to the minutes? (pause) Hearing none, if there are no objections, the minutes are approved as printed."


Set goals, objectives or some context for this meeting.

Discussion items


Admin Kick offLaura
  • Please remember to log your attendance for any PH WG session you attend
  • Remember a number of WG co-chair seats up for election in 2021
    • Please reach out to a co-chair if you have any questions about the role or the nomination process
  • Agenda as reviewed, no updates
    • Note that Wednesday Q4 there is a Government Birds of a Feather session that may be of interest

RBC PhenotypingJohn Spinosa
  • Presentation
  • FHIR IG project proposal for extended RBC phenotyping
    • Lantana supported project
  • San Diego Blood Bank is genotyping donors for red blood cell donors
  • Blood donor centers manufacture the products
  • Regional blood banks are typically not-for-profit (eg Red Cross, Wisconsin Blood Center)
    • They fall under FDA oversight and federal regulations
    • Tend to be fragmented systems in the US
  • Health system blood banks track the use of the products
  • There is a Public Health role in reporting adverse events from transfusions
  • Data needs to be transferred from the donor centers to the health systems
    • Health systems are rekeying the information
    • The amount of data being conveyed is growing due to advances in molecular techniques
    • The blood product inventory often doesn't stay local
      • Product searches can be regional or national
    • Donors can become patients, so this can be important for patient care too
  • Proposal to develop a FHIR IG
    • Supporters include the San Diego Blood Bank and HaploGNX
      • Vendors are being contacted about joining
    • Talking to O&O and Clinical Genomics WG as well as PH
  • Possible use cases:
    • Inventory management at the blood banks and health systems
      • Optimize products for patient care
    • Queries to blood bank suppliers
      • Queries for specialized units, which tend to be manual (fax) today
    • Can be used to track adverse events too
  • It's not clear yet if the scope of data being exchanged will focus on phenotypic or genotypic data
    • Will receiving systems typically use this information for documentation or will they need more discrete data to run logic on?
      • Phenotypes typically are less granular than genotypes
      • The phenotype may be more useful for most clinicians
        • May need to be able to query for more discrete genotypic data (likely an edge case)
  • Security and privacy considerations
    • Will patient data be exchanged? What are the privacy/security considerations?
    • There are a couple of different types of patients in the use cases
      • The patient requiring the product
        • The biological requirements for product shouldn't be particularly patient identifiable
      • The donor if they ever become a patient and require care (and maybe products)
  • Blood as a resource may fit in the SANER project
  • The project team will put together a project proposal between now and the Sept WGM
  • Reach out to John if you have additional questions

Maternal and Infant Health ProjectRuby Nash/David DeRoode
  • PSS-1802 - Getting issue details... STATUS
  • NIH sponsored Longitudinal Maternal and Infant Health Information for Research FHIR IG
    • Dan Chaput at ONC has been working with NIH on this project
    • Part of the larger PCOR project
    • There is an interaction with USCDI as well
      • There were many comments in Fall 2020 about adding pregnancy and delivery related data classes and data elements to USCDI (but they didn't make it into the draft Version 2)
    • The project will have a TEP including folks from NCHS
  • Data scope includes pregnancy, deliver and post-partum (~1 year) phase
  • Primarily for research purposes
    • 8 example use cases from NIH
    • The goal is to develop a reusable infrastructure
    • Not sure yet if this would be a Push versus a Query workflow (could be both)
    • Both singular query and bulk query could be in scope
      • Would be driven by the research question
      • Could be subscription based too
      • Is there an overlap with CodeX work on clinical trial and patient matching use case?
  • Potentially a significant overlap with existing IGs (Vital Records, Birth Defects, MedMorph, case reporting, etc)
    • Could be a MedMorph use case or a part of the US Public Health library
    • The Vulcan Accelerator may also be relevant

Action items